ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Firm To Study Imaging System As Adjunct To Mammogram.

February 25, 2000

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

September 24, 2010

Coalition Agrees On Method To Coordinate Issues

March 21, 1980